Richard L. Gelfond - 02 Jan 2026 Form 4 Insider Report for IMAX CORP (IMAX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
05 Jan 2026, 17:24:39 UTC
Prior SEC filing
12 Nov 2025
Next SEC filing
10 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Richard L. Gelfond

Key filing fact

Richard L. Gelfond filed Form 4 for IMAX CORP (IMAX) on 05 Jan 2026.

Key facts

  • This page summarizes Richard L. Gelfond's Form 4 filing for IMAX CORP (IMAX).
  • 10 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 05 Jan 2026, 17:24.

Change

  • Previous filing in this sequence was filed on 12 Nov 2025.
  • Current net transaction value: -$3,201,710.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0000944011 Primary reporting owner

GELFOND RICHARD L

Relationship
Chief Executive Officer, Director
Address
902 BROADWAY, 20TH FLOOR, NEW YORK
Signature
/s/ Richard L. Gelfond
Signature date
05 Jan 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMAX transaction

common shares

Options Exercise

Transaction value
$0
Shares
+62,529
Change %
+11%
Price
$0.000000
Shares after
627,128
Date
02 Jan 2026
Ownership
Direct
Footnotes
F1
IMAX transaction

common shares

Tax liability

Transaction value
$1,255,621
Shares
-34,859
Change %
-5.6%
Price
$36.02
Shares after
592,269
Date
02 Jan 2026
Ownership
Direct
Footnotes
F2
IMAX transaction

common shares

Options Exercise

Transaction value
$0
Shares
+61,193
Change %
+10%
Price
$0.000000
Shares after
653,462
Date
02 Jan 2026
Ownership
Direct
Footnotes
F1
IMAX transaction

common shares

Tax liability

Transaction value
$1,218,917
Shares
-33,840
Change %
-5.2%
Price
$36.02
Shares after
619,622
Date
02 Jan 2026
Ownership
Direct
Footnotes
F2
IMAX transaction

common shares

Options Exercise

Transaction value
$0
Shares
+36,506
Change %
+5.9%
Price
$0.000000
Shares after
656,128
Date
02 Jan 2026
Ownership
Direct
Footnotes
F1
IMAX transaction

common shares

Tax liability

Transaction value
$727,172
Shares
-20,188
Change %
-3.1%
Price
$36.02
Shares after
635,940
Date
02 Jan 2026
Ownership
Direct
Footnotes
F2
IMAX holding

common shares (opening balance)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
564,599
Date
02 Jan 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMAX transaction Derivative

restricted share units

Options Exercise

Transaction value
$0
Shares
-62,529
Change %
-100%
Price
$0.000000
Shares after
0
Date
02 Jan 2026
Ownership
Direct
Underlying class
common shares
Underlying amount
62,529
Exercise price
$0.000000
Footnotes
F1, F3, F4, F5, F9
IMAX transaction Derivative

restricted share units

Options Exercise

Transaction value
$0
Shares
-61,193
Change %
-50%
Price
$0.000000
Shares after
61,193
Date
02 Jan 2026
Ownership
Direct
Underlying class
common shares
Underlying amount
61,193
Exercise price
$0.000000
Footnotes
F1, F3, F4, F6, F9
IMAX transaction Derivative

restricted share units

Options Exercise

Transaction value
$0
Shares
-36,506
Change %
-33%
Price
$0.000000
Shares after
73,012
Date
02 Jan 2026
Ownership
Direct
Underlying class
common shares
Underlying amount
36,506
Exercise price
$0.000000
Footnotes
F3, F4, F7, F9
IMAX transaction Derivative

restricted share units

Award

Transaction value
$0
Shares
-97,357
Change %
-50%
Price
$0.000000
Shares after
97,357
Date
02 Jan 2026
Ownership
Direct
Underlying class
common shares
Underlying amount
97,357
Exercise price
$0.000000
Footnotes
F3, F4, F8, F9
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Represents the conversion of vested restricted share units into common shares.

Footnote F2

Mr. Gelfond is reporting the withholding of common shares by IMAX Corporation to satisfy the tax withholding obligation in connection with the delivery of common shares upon conversion of the restricted share unit transaction.

Footnote F3

Each restricted share unit represents a contingent right to receive one common share of IMAX Corporation.

Footnote F4

Each restricted share unit is the economic equivalent of one common share of IMAX Corporation.

Footnote F5

The restricted share units vest and will be converted to common shares in three installments: 62,528 on each of January 2, 2024 and January 2, 2025 and 62,529 on January 2, 2026.

Footnote F6

The restricted share units vest and will be converted to common shares in three installments: 61,192 on January 2, 2025 and 61,193 on each of January 2, 2026 and January 2, 2027.

Footnote F7

The restricted share units vest and will be converted to common shares in three installments: 36,506 on each of January 2, 2026, January 2, 2027 and January 2, 2028.

Footnote F8

The restricted share units vest and will be converted to common shares in three installments: 32,452 on each of January 2, 2027, January 2, 2028 and 32,453 January 2, 2029.

Footnote F9

This represents the number of restricted share units for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,818,695; 231,562 and 635,940 respectively.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .